Search results
The Difference Between Shorting ETFs and Inverse ETFs (and Which Is More Risky)
Lifehacker· 12 hours agoFor traders looking to profit from a declining market, shorting exchange-traded funds (ETFs) and...
Investors in Hap Seng Plantations Holdings Berhad (KLSE:HSPLANT) have seen favorable returns of 36%...
Simply Wall St. via Yahoo Finance· 1 hour agoWhat About Dividends? It...Plantations Holdings Berhad provided a TSR of 4.2% over the last twelve...
Pros and cons of a business line of credit
Bankrate via Yahoo Finance· 6 hours agoInvoice factoring Invoice factoring involves selling your unpaid invoices for cash. Most factoring companies offer up to 85 percent of the invoice value....
Time to Pounce: 2 Ultra-High-Yield Monthly Dividend Stocks Begging to Be Bought in May
Motley Fool via Yahoo Finance· 16 hours agoTo round things out, all but $0.2 million of the company's $1.09 billion in debt securities are...
Apple earnings results: Tim Cook announces biggest-ever stock buyback of $110 billion as sales and...
Business Insider via Yahoo News· 5 hours agoThe bank said it expects a 20% year-over-year decline in Apple's China iPhone business, as well as...
Should You Buy the Cheapest Trillion-Dollar Stock Hand Over Fist? Wall Street Says Yes
Motley Fool via Yahoo Finance· 16 hours agoThe Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and ...
Op-Ed | Who Could Buy TikTok?
The Business of Fashion· 9 hours agoByteDance Ltd.’s Hail Mary legal effort to avoid selling or shutting down TikTok relies on convincing a judge the social network will disappear entirely,...
The Best New Restaurants In Las Vegas
Forbes· 20 hours agoWhile some might argue that the best way to get to know a place as sensory saturated as Las Vegas is to get out and explore, to truly experience this...
5 ways investors can separate themselves from the pack
Financial Post via Yahoo Finance· 15 hours agoSino-Forest Corp. was a famous fraud where short-selling analysts discovered the company didn’t own...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 20 hours agoAs of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market share...
